As Novo Nordisk launches first FDA-approved oral weight loss medication, independent examination evaluates Ro's direct-to-patient distribution model, pricing transparency, and telehealth access ...
As we head into 2026, the variable market is becoming increasingly unpredictable, which means fixed ops will play an even bigger role in dealership performance. Joining us on the latest episode of ...
Following the announcement on January 1, 2026, that Chelsea has parted company with Enzo Maresca, the focus has immediately shifted to Liam Rosenior as a leading candidate for the vacancy. With ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results